MARATHON ASSET MANAGEMENT LP

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.

Issuer % of Class Filed
John Hancock Marathon Asset-Based Lending Fund 13G/A Amendment 7
478025109
0% 7/14/2026
Event 7/8/2026
Keenova Therapeutics plc 13G/A Amendment 3
MNKTQ · G5890A102
6.8% 5/15/2026
Event 3/31/2026
Graftech International Ltd 13G/A Amendment 2
EAF · 384313508
4.7% 5/15/2026
Event 3/31/2026
John Hancock Marathon Asset-Based Lending Fund 13G/A Amendment 6
478025109
12.9% 2/17/2026
Event 12/31/2025
John Hancock Marathon Asset-Based Lending Fund 13G/A Amendment 5
478025109
14.6% 11/14/2025
Event 9/30/2025
Mallinckrodt plc 13G/A Amendment 2
MNKTQ · G5890A102
7.7% 11/14/2025
Event 9/30/2025
John Hancock Marathon Asset-Based Lending Fund 13G/A Amendment 4
478025109
16.7% 8/14/2025
Event 6/30/2025
Endo, Inc. 13G/A Amendment 1
NDOI · 29290D117
8.0% 5/15/2025
Event 3/31/2025
Graftech International Ltd 13G/A Amendment 1
EAF · 384313508
7.5% 5/15/2025
Event 3/31/2025
Graftech International Ltd 13G
EAF · 384313508
5.5% 2/27/2025
Event 2/20/2025